Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) traded down 5.2% on Tuesday . The company traded as low as $39.86 and last traded at $39.86. 1,102 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 1,352 shares. The stock had previously closed at $42.05.
Hikma Pharmaceuticals Stock Performance
The firm has a 50-day moving average of $40.06 and a 200-day moving average of $39.19.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
